- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 24, 2025 | 3.87M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 3.84M sh |
| Capex | FY 2024 · Dec 31, 2023 | $68.89M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$24.24M |
| Long Term Debt restated | FY 2024 · Dec 31, 2023 | $4.5M |
| Short Term Debt restated | FY 2024 · Dec 31, 2023 | $524.46K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $8.2M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $14.77M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $22.53M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $31.01M |
| Total Assets | FY 2024 · Dec 31, 2023 | $187.55M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$7.17 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$7.17 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $12.52M |
| Rd Expense restated | FY 2024 · Dec 31, 2023 | $506.24K |
| Net Income | FY 2024 · Dec 31, 2023 | −$27.56M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$13.67M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $191.92M |